ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1030

Readability of Participant Information and Consent Forms for Rheumatology Clinical Trial Participants

Stephen Hall1, Gail Grant2 and Christina Meyer2, 1Melbourne Rheumatology, Melbourne, Australia, 2emeritus research, melbourne, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Clinical research, Education, educational research and ethics, patient

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose:  To determine the readability of written information (Participant Information and Consent Forms [PICS]) provided to clinical trial participants prior to enrolment into a clinical trial. General recommendations for reading age are that reading materials should be at educational level of year 8 or below

Methods: PICS over a time frame 2003-2013 from a dedicated clinical trials site were assessed for reading age.  81 industry derived PICs for musculoskeletal studies , 4 investigator initiated PICS and 3 non–drug study PICS were reviewed using a number of validated reading age tools -Flesch Reading Ease; Gunning FOG; Flesch-Kincaid Grade Level; The Coleman Liau Index; The SMOG Index; Automated Reading Index; Linsear Write Formula readability scores – to estimate readability of specific subsections. Specific sub-sections of the PICs from industry sponsored studies were reviewed – confidentiality/privacy section and the Risk Section.

Results: Only 4% of documents conformed to a recommended reading age of year 8 or below. The majority of documents had high reading ages with 93-96% pitched at year 10 or greater. 34 – 70% required reading levels of college graduate or postgraduate. A study of a small number of non-industry studies demonstrated similar results

Conclusion:

Current information materials provided to potential clinical trial participants fall far short of recommended readability levels potentially compromising the process of informed consent. Further attention needs to be paid to this aspect of clinical trials


Disclosure:

S. Hall,
None;

G. Grant,
None;

C. Meyer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/readability-of-participant-information-and-consent-forms-for-rheumatology-clinical-trial-participants/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology